Research In Brief
This article was originally published in The Gray Sheet
Executive Summary
Covidien's Pipeline aneurysm device shows 8.5% major complication rate in early post-market results. Surprise at long-term results for endovascular repair of abdominal aortic aneurysms. More clinical trial news.